Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6012)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2013 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shen YY, Lu YC, Shen DP, Liu YJ, Su XY, Zhu GS, Yin XL, Ni XZ. Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients. World J Gastroenterol 2013; 19(28): 4568-4575 [PMID: 23901234 DOI: 10.3748/wjg.v19.i28.4568] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i28/4568.htm |
| Number | Citing Articles |
| 1 |
Eva Wimmer, Stephan Ihrler, Olivier Gires, Sylvia Streit, Wolfgang Issing, Christoph Bergmann. Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas. World Journal of Clinical Oncology 2019; 10(3): 136-148 doi: 10.5306/wjco.v10.i3.136
|
| 2 |
Daniela Lazar, Sorina Taban, Marioara Cornianu, Alexandra Faur, Ioan Romosan, Adrian Goldis. Gastric Cancer. 2017; doi: 10.5772/intechopen.69737
|
| 3 |
Li Tan, Jun Wang, Junko Tanizaki, Zhifeng Huang, Amir R. Aref, Maria Rusan, Su-Jie Zhu, Yiyun Zhang, Dalia Ercan, Rachel G. Liao, Marzia Capelletti, Wenjun Zhou, Wooyoung Hur, NamDoo Kim, Taebo Sim, Suzanne Gaudet, David A. Barbie, Jing-Ruey Joanna Yeh, Cai-Hong Yun, Peter S. Hammerman, Moosa Mohammadi, Pasi A. Jänne, Nathanael S. Gray. Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors. Proceedings of the National Academy of Sciences 2014; 111(45) doi: 10.1073/pnas.1403438111
|
| 4 |
Sang Hee Cho, Chang Soo Hong, Hee Nam Kim, Min Ho Shin, Ka Rham Kim, Hyun Jeong Shim, Jun Eul Hwang, Woo Kyun Bae, Ik Joo Chung. FGFR4 Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal Transition. Cancer Research and Treatment 2017; 49(3): 766 doi: 10.4143/crt.2016.457
|
| 5 |
Luyao Chen, Zhengwei Lei, Xin Ma, Qingbo Huang, Xu Zhang, Yong Zhang, Peng Hao, Minggang Yang, Xuetao Zhao, Jun Chen, Gongxue Liu, Tao Zheng. Prognostic significance of fibroblast growth factor receptor 4 polymorphisms on biochemical recurrence after radical prostatectomy in a Chinese population. Scientific Reports 2016; 6(1) doi: 10.1038/srep33604
|
| 6 |
Jung Han Kim, Soo Young Jeong, Hyun Joo Jang, Sung Taek Park, Hyeong Su Kim. FGFR4 Gly388Arg Polymorphism Reveals a Poor Prognosis, Especially in Asian Cancer Patients: A Meta-Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.762528
|
| 7 |
Abdolkarim Moazeni-Roodi, Sahel Sarabandi, Shima Karami, Mohammad Hashemi, Saeid Ghavami. An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer. Bioscience Reports 2020; 40(10) doi: 10.1042/BSR20192051
|
| 8 |
Ming-Jen Sheu, Ming-Ju Hsieh, Whei-Ling Chiang, Shun-Fa Yang, Hsiang-Lin Lee, Liang-Ming Lee, Chao-Bin Yeh, Ming-Hsien Chien. Fibroblast Growth Factor Receptor 4 Polymorphism Is Associated with Liver Cirrhosis in Hepatocarcinoma. PLOS ONE 2015; 10(4): e0122961 doi: 10.1371/journal.pone.0122961
|
| 9 |
Pin Wang, Yunshan Wang, Bo Hang, Xiaoping Zou, Jian-Hua Mao. A novel gene expression-based prognostic scoring system to predict survival in gastric cancer. Oncotarget 2016; 7(34): 55343 doi: 10.18632/oncotarget.10533
|
| 10 |
Chang‐Soo Hong, Eun‐Gene Sun, Ji‐Na Choi, Dae‐Hwan Kim, Jo‐Heon Kim, Kyung‐Hyun Ryu, Hyun‐Jeong Shim, Jun‐Eul Hwang, Woo‐Kyun Bae, Hyeong‐Rok Kim, Kyung Keun Kim, Chaeyong Jung, Ik‐Joo Chung, Sang‐Hee Cho. Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer. Cancer Science 2020; 111(9): 3268 doi: 10.1111/cas.14526
|
| 11 |
Ya-Ping Li, Lin Zhang, Yu-Liang Zou, Yan Yu. Association between FGFR4 gene polymorphism and high-risk HPV infection cervical cancer. Asian Pacific Journal of Tropical Medicine 2017; 10(7): 680 doi: 10.1016/j.apjtm.2017.07.008
|
| 12 |
Dheepak Kanagavel, Mikhail Fedyanin, Alexey Tryakin, Sergei Tjulandin. Second-line treatment of metastatic gastric cancer: Current options and future directions. World Journal of Gastroenterology 2015; 21(41): 11621-11635 doi: 10.3748/wjg.v21.i41.11621
|
| 13 |
Tao Peng, Yangyang Sun, Zhiwei Lv, Ze Zhang, Quanxin Su, Hao Wu, Wei Zhang, Wei Yuan, Li Zuo, Li Shi, Li-Feng Zhang, Xiaoli Zhou, Yuanyuan Mi. Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-020-80146-y
|
| 14 |
Si-Wei Xiong, Jianqun Ma, Fen Feng, Wen Fu, Shan-Rong Shu, Tianjiao Ma, Caixia Wu, Guo-Chang Liu, Jinhong Zhu. FunctionalFGFR4Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis. Oncotarget 2017; 8(15): 25300 doi: 10.18632/oncotarget.15811
|
| 15 |
Chang Shu, Jinhuan Wang. Association between FGFR4 Gly388Arg polymorphism (rs351855) and cancer risk: A meta analysis including 10,584 subjects. Meta Gene 2017; 13: 32 doi: 10.1016/j.mgene.2017.04.003
|